Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:      
Net loss $ (1,046,830) $ (3,387,295) $ (4,475,305)
Adjustments to reconcile net loss to cash used in operating activities:      
Depreciation 799 2,397 1,788
Stock-based compensation   397,470 372,196
Decrease to fair value of derivative liability 0 (1,000,000) (108,944)
Inventory obsolescence charge   248,073 181,988
Gain on forgiveness of loan 0 0 (178,229)
Changes in operating assets and liabilities:      
Inventory   (582,572) (42,215)
Prepaid expenses and other current assets   223,854 (163,135)
Accounts payable   1,288,130 (64,853)
Accrued interest   119,671 110,956
Accrued expenses and other liabilities   (96,370) (80,324)
Net cash used in operating activities   (2,786,642) (4,446,077)
Cash flows from investing activities:      
Purchases of property and equipment   0 (3,275)
Net cash used in investing activities   0 (3,275)
Cash flows from financing activities:      
Proceeds received from advances from investors   575,000 0
Proceeds received from series 2 convertible notes   0 1,050,000
Proceeds from issuance common stock and warrants, net of financing costs   0 6,219,233
Net cash provided by financing activities   575,000 7,269,233
Net increase (decrease) in cash   (2,211,642) 2,819,881
Cash, beginning of period   2,266,639 959,309
Cash, end of period $ 54,977 54,977 3,779,190
Non-cash financing activities:      
Issuance of restricted stock for services   $ 29,831 $ 103,750